Frazier Life Sciences
Palo Alto, US · Seed → Growth
Their stated focus (public profile)
Frazier Life Sciences is a biotech-focused investment firm that manages both venture capital and public equity strategies to advance novel therapeutics. The venture strategy emphasizes company creation and early-stage (Series A/B/C) private biopharmaceutical investments with meaningful equity ownership, while the public equity strategy focuses on small and mid-cap publicly traded biopharma companies and private crossover opportunities. The firm targets product-focused companies developing transformational therapeutics across oncology, orphan diseases, autoimmune, and other major therapeutic areas.
Stages: Seed → Growth
Sectors: Life sciences, Bone, Cardiometabolic, Cns, Liver, Respiratory, Vaccines
On file: 14 companies on record
Website: frazierls.com
This perch was compiled from public sources — filings, the fund’s own site, public write-ups. None of it is the fund’s own words.
Is this your fund? Request a correction or removal.
Search the funds we have on file
Looking for investors? Search the funds we have on file — what they back, where they are, and whether your raise fits. Sign in and Percy matches you to the right ones.
Looking to claim your own fund? Start here →
This perch was compiled from public sources — filings, the fund’s own site, public write-ups. None of it is the fund’s own words.
Funds closest to this thesis
Ordered by how close each thesis sits to this one.
Is this your fund? Request a correction or removal.